February 16, 2005
Speaker Biographies
Ernst R. Berndt is the Louis B. Seley Professor of Applied Economics at the MIT Sloan School of Management and Director of the National Bureau of Economic Research Program on Technological Progress and Productivity Measurement. He also is an Adjunct Professor of Health Care Policy and Management at the Harvard Medical School, and serves as Co-Director of the MIT-Harvard Biomedical Enterprise Program. Professor Berndt received his Ph.D. in economics from the University of Wisconsin – Madison, has been awarded an honorary doctorate degree from Uppsala University in Sweden, and is an elected Fellow of the Econometric Society. At MIT, Professor Berndt has taught courses in econometrics, health care economics, and industrial organization. He also recently completed terms as Chair, Federal Economic Statistics Advisory Committee, and as a panel review member at the National Science Foundation, Program on Methodology, Measurement and Statistics.
Scott Gottlieb, M.D. is a former senior policy adviser to the Commissioner of the Food and Drug Administration (FDA) and to the Administrator of the Centers for Medicare and Medicaid Services (CMS) at the Department of Health and Human Services. At AEI, Dr. Gottlieb researches FDA and CMS regulatory policies, the development of new medical technology, and political and clinical trends in medicine. Dr. Gottlieb is also the author of the new Forbes/Gottlieb Medical Technology Report, an investment newsletter.
Adrian H. B. Gottschalk is a senior manager in Biogen Idec’s corporate strategy group. He is a graduate of the Sloan School of Management at MIT and the joint Harvard Medical School / MIT Biomedical Enterprise Program where he received his M.B.A. and S.M. degrees respectively. Prior to attending MIT, Mr. Gottschalk was a consultant for PricewaterhouseCoopers in Dallas, TX. He also was an independent consultant to the business development group at Allergan Pharmaceuticals. Adrian's thesis for the biomedical enterprise program focused on evaluating the cost/benefits of PDUFA and improving the efficiency of the later stages of the drug development process.
Robert W. Hahn is co-founder and executive director of the American Enterprise Institute-Brookings Joint Center and a resident scholar at AEI. Previously, he worked for the Council of Economic Advisers. He also has served on the faculties of Harvard University and Carnegie Mellon University. Dr. Hahn frequently contributes to leading scholarly journals and general-interest periodicals, including the American Economic Review, Yale Law Journal, Science, and the New York Times. He is the author of Reviving Regulatory Reform: A Global Perspective and In Defense of the Economic Analysis of Regulation. In addition, Dr. Hahn is co-founder of the Community Preparatory School––an inner-city middle school in Providence, Rhode Island, that provides opportunities for disadvantaged youth to achieve their full potential.
Randall Lutter, Ph.D., is Chief Economist in the Office of Planning at the Food and Drug Administration at the Department of Health and Human Services. Previously a fellow at the AEI-Brookings Joint Center for Regulatory Studies, he has served as senior economist at the President's Council of Economic Advisers and at the Office of Management and Budget. He taught economics while on the faculty of the School of Management at the State University of New York at Buffalo. His writings have appeared in a variety of journals including Environmental Science & Technology, the Journal of Political Economy, Regulation, and Science.
Amit K. Sachdev was appointed to serve as the Deputy Commissioner for Policy at the FDA in April of 2004. As the second-ranking senior official, he guides all policy and legislative affairs for the Agency. Mr. Sachdev was Associate Commissioner for Legislation at the Food and Drug Administration from 2002-2004. Prior to joining FDA, from 2000-2002, Mr. Sachdev served as Majority Counsel to the Committee on Energy and Commerce for Chairman W.J. “Billy” Tauzin. From 1998-2000, Mr. Sachdev served as Counsel to the Committee on Commerce for Chairman Tom Bliley. Before working on the Hill, Mr. Sachdev was an Associate at the law firm of Ropes and Gray in Washington D.C., handling legislative and regulatory matters, as well as litigation. From 1993-1997, Mr. Sachdev was Counsel for the Chemical Manufacturers Association in Arlington, Virginia. He has a law degree from Emory University and a Bachelor of Science from Carnegie Mellon University.
View Event Details
